These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 18669473)

  • 21. Carbonic anhydrase IX as a predictive biomarker of response to kidney cancer therapy.
    Signoretti S; Regan M; Atkins M
    BJU Int; 2008 Jun; 101 Suppl 4():31-5. PubMed ID: 18430120
    [No Abstract]   [Full Text] [Related]  

  • 22. The use of positron-emission tomography in the diagnosis of tumour phenotype.
    Divgi C
    BJU Int; 2008 Jun; 101 Suppl 4():36-8. PubMed ID: 18430121
    [No Abstract]   [Full Text] [Related]  

  • 23. The pathway to biomarker discovery: carbonic anhydrase IX and the prediction of immune responsiveness.
    Panelli MC; Wang E; Marincola FM
    Clin Cancer Res; 2005 May; 11(10):3601-3. PubMed ID: 15897553
    [No Abstract]   [Full Text] [Related]  

  • 24. G250: a carbonic anhydrase IX monoclonal antibody.
    Lam JS; Pantuck AJ; Belldegrun AS; Figlin RA
    Curr Oncol Rep; 2005 Mar; 7(2):109-15. PubMed ID: 15717944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of carbonic anhydrase IX as a molecular marker for transitional cell carcinoma of the bladder.
    Klatte T; Belldegrun AS; Pantuck AJ
    BJU Int; 2008 Jun; 101 Suppl 4():45-8. PubMed ID: 18430124
    [No Abstract]   [Full Text] [Related]  

  • 26. Application of monoclonal antibody G250 recognizing carbonic anhydrase IX in renal cell carcinoma.
    Oosterwijk-Wakka JC; Boerman OC; Mulders PF; Oosterwijk E
    Int J Mol Sci; 2013 May; 14(6):11402-23. PubMed ID: 23759990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current status and future directions of molecular markers in renal cell carcinoma.
    Rini BI
    Curr Opin Urol; 2006 Sep; 16(5):332-6. PubMed ID: 16905977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomarkers in renal cell carcinoma.
    McGuire BB; Fitzpatrick JM
    Curr Opin Urol; 2009 Sep; 19(5):441-6. PubMed ID: 19584732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical and immunologic diagnosis of cancer. Renal and transitional carcinomas.
    Cordon-Cardo C
    Tumour Biol; 1987; 8(2-3):94-102. PubMed ID: 3329405
    [No Abstract]   [Full Text] [Related]  

  • 30. Kidney cancer: Finding a niche for girentuximab in metastatic renal cell carcinoma.
    Pal SK; Agarwal N
    Nat Rev Urol; 2016 Aug; 13(8):442-3. PubMed ID: 27349371
    [No Abstract]   [Full Text] [Related]  

  • 31. Monoclonal antibodies to renal cancer antigens.
    Bander NH
    Eur Urol; 1990; 18 Suppl 2():10-2. PubMed ID: 2226594
    [No Abstract]   [Full Text] [Related]  

  • 32. [An immunohistochemical study and its clinical application for endocrine disorders using monoclonal antibodies].
    Shimizu K; Eisenbarth GS; Shoji T
    Nihon Ika Daigaku Zasshi; 1991 Dec; 58(6):615-20. PubMed ID: 1770115
    [No Abstract]   [Full Text] [Related]  

  • 33. Overview of immunocytochemical approaches to the differential diagnosis of tumors. Diagnostic applications in the clinical laboratory.
    Frisman DM
    Methods Mol Biol; 1994; 34():405-27. PubMed ID: 7711869
    [No Abstract]   [Full Text] [Related]  

  • 34. Tumor markers: from laboratory to clinical utility.
    Schrohl AS; Holten-Andersen M; Sweep F; Schmitt M; Harbeck N; Foekens J; Brünner N;
    Mol Cell Proteomics; 2003 Jun; 2(6):378-87. PubMed ID: 12813140
    [No Abstract]   [Full Text] [Related]  

  • 35. Cell, tissue and organ specific tumor markers: an overview.
    Damjanov I
    Curr Top Pathol; 1987; 77():367-84. PubMed ID: 3322698
    [No Abstract]   [Full Text] [Related]  

  • 36. Carbonic anhydrase IX expression in clear cell renal cell carcinomas negatively correlates with the proportion of the granular cell component.
    Skapa P; Hyrsl L; Zavada J; Soukup J; Zamecnik J
    J Clin Oncol; 2008 Aug; 26(22):3809-11; author reply 3811-2. PubMed ID: 18669473
    [No Abstract]   [Full Text] [Related]  

  • 37. Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy.
    Stillebroer AB; Mulders PF; Boerman OC; Oyen WJ; Oosterwijk E
    Eur Urol; 2010 Jul; 58(1):75-83. PubMed ID: 20359812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbonic anhydrase IX: historical and future perspectives.
    Oosterwijk E
    BJU Int; 2008 Jun; 101 Suppl 4():2-7. PubMed ID: 18430115
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular mechanisms of carbonic anhydrase IX-mediated pH regulation under hypoxia.
    Pastorekova S; Ratcliffe PJ; Pastorek J
    BJU Int; 2008 Jun; 101 Suppl 4():8-15. PubMed ID: 18430116
    [No Abstract]   [Full Text] [Related]  

  • 40. Carbonic anhydrase expression in kidney and renal cancer: implications for diagnosis and treatment.
    Oosterwijk E
    Subcell Biochem; 2014; 75():181-98. PubMed ID: 24146380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.